Puma Biotechnology Releases Updated Corporate Presentation
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
Here's Why Puma Biotechnology Fell 17.2% in April | The Motley Fool
Puma Biotechnology, Inc. (PBYI) Message Board | InvestorsHub
Puma Biotechnology settles with Novartis' Sandoz unit over Nerlynx patent dispute (PBYI) | Seeking Alpha
Puma Biotechnology Announces Publication of Phase II Clinical Trial of Alisertib in JAMA Oncology | Business Wire
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
Former Puma Biotech executive gets U.S. prison term for insider trading
Stocks to Watch: Dropbox, Nike, Tronc, Qualcomm, Puma Biotechnology, Invitation Homes, Universal Display - WSJ
Puma Biotechnology Presents Outcomes from the Metastatic Breast Cancer Cohort of the SUMMIT Trial at the ASCO 2022 Annual Meeting
Puma Biotechnology 獲Alisertib 授權，與武田共創雙贏! | GeneOnline News
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
Puma Biotechnology
Puma Biotechnology Grants Inducement Stock Awards to New Non-Executive Employees.
Conspiracy Theory: Did Puma Biotech Exec Resign Because of Bad News Ahead? | BioSpace
Puma Biotechnology
Puma Biotechnology
PumaBiotech (@pumabiotech) / Twitter
Puma Biotechnology, Inc.
Puma Biotechnology (PBYI) Stock Climbs On Orphan Drug Designation | Alpha Stock News
Puma Biotechnology sinks after Europe unlikely to OK breast cancer drug - Nigeria News
Puma Biotechnology falls more than 20%
Puma Biotechnology: Too Little, Too Late, Too Much Of A Bad Side Effect (NASDAQ:PBYI) | Seeking Alpha
PumaBiotech (@pumabiotech) / Twitter
Puma shares nearly triple on drug news, but options smell 'fishy'
